Kiniksa Pharmaceuticals International (KNSA) Current Assets (2017 - 2026)
Kiniksa Pharmaceuticals International (KNSA) reported Current Assets of $668.63 million for Q2 2026, up 59.1% from $420.31 million a year earlier and up 12.5% from the prior quarter.
Powered by 
Analysis
Kiniksa Pharmaceuticals International (KNSA) Current Assets (2017 - 2026) Analysis & Trends
At the end of FY2025, Kiniksa Pharmaceuticals International posted Current Assets of $527.18 million, up 58.9% from FY2024.
- Current Assets has increased for four consecutive years, with a five-year compound annual growth rate of 9.6% (FY2020 to FY2025).
- By year, Current Assets came in at $331.8 million in FY2024 (+20.1%), $276.3 million in FY2023 (+13.7%), $243.06 million in FY2022 (+23.7%) and $196.45 million in FY2021 (-41.1%).
- The Q2 2026 figure ranks as the highest quarterly Current Assets in data going back to Q4 2017.
- Year over year, Current Assets has now increased in each of the last 16 quarters, with growth averaging 43.8% over the last eight quarters.
- The high point for year-over-year Current Assets in five years was Q1 2026 (growth of 66.9%); the low point was Q3 2021 (a decline of 42.5%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $594.17 million (Q1 2026), $527.18 million (Q4 2025) and $475.53 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.42 Bn | 1,106.00 Bn | 19.71 Bn | 64.67 Bn |
| 2 | Johnson & Johnson | 617.98 Bn | 536.51 Bn | 17.26 Bn | 59.77 Bn |
| 3 | AbbVie | 502.80 Bn | 475.92 Bn | 12.70 Bn | 33.67 Bn |
| 4 | Merck | 368.67 Bn | 323.05 Bn | 12.21 Bn | 36.68 Bn |
| 5 | Novartis Ag | 298.36 Bn | 262.35 Bn | 11.24 Bn | 27.35 Bn |
| 6 | Astrazeneca | 261.17 Bn | 234.85 Bn | 12.86 Bn | 27.97 Bn |
| 7 | Amgen | 237.18 Bn | 192.58 Bn | 7.24 Bn | 34.96 Bn |
| 8 | Gilead Sciences | 191.11 Bn | 165.31 Bn | 6.22 Bn | 13.95 Bn |
| 9 | Pfizer | 169.83 Bn | 116.48 Bn | 10.94 Bn | 41.36 Bn |
| 10 | Kiniksa Pharmaceuticals International | 6.23 Bn | 4.97 Bn | 220.03 Mn | 668.63 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 668.63 Mn |
| Mar 31, 2026 | 594.17 Mn |
| Dec 31, 2025 | 527.18 Mn |
| Sep 30, 2025 | 475.53 Mn |
| Jun 30, 2025 | 420.31 Mn |
| Mar 31, 2025 | 355.91 Mn |
| Dec 31, 2024 | 331.80 Mn |
| Sep 30, 2024 | 311.30 Mn |
| Jun 30, 2024 | 301.02 Mn |
| Mar 31, 2024 | 270.59 Mn |
| Dec 31, 2023 | 276.30 Mn |
| Sep 30, 2023 | 256.11 Mn |
| Jun 30, 2023 | 246.04 Mn |
| Mar 31, 2023 | 231.50 Mn |
| Dec 31, 2022 | 243.06 Mn |
| Sep 30, 2022 | 241.82 Mn |
| Jun 30, 2022 | 179.94 Mn |
| Mar 31, 2022 | 198.76 Mn |
| Dec 31, 2021 | 196.45 Mn |
| Sep 30, 2021 | 217.51 Mn |
API Access
Kiniksa Pharmaceuticals International Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=KNSA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "KNSA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=KNSA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();